Literature DB >> 28376161

Tissue Acquisition in Clinical Trials-Essential for Progress.

S Percy Ivy1, Jeffrey S Abrams1.   

Abstract

Mesh:

Year:  2017        PMID: 28376161      PMCID: PMC6279256          DOI: 10.1093/jnci/djx003

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  12 in total

1.  Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective.

Authors:  Shashi Amur; Felix W Frueh; Lawrence J Lesko; Shiew-Mei Huang
Journal:  Biomark Med       Date:  2008-06       Impact factor: 2.851

2.  Trastuzumab in the treatment of breast cancer.

Authors:  Gabriel N Hortobagyi
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

3.  Fit-for-purpose method development and validation for successful biomarker measurement.

Authors:  Jean W Lee; Viswanath Devanarayan; Yu Chen Barrett; Russell Weiner; John Allinson; Scott Fountain; Stephen Keller; Ira Weinryb; Marie Green; Larry Duan; James A Rogers; Robert Millham; Peter J O'Brien; Jeff Sailstad; Masood Khan; Chad Ray; John A Wagner
Journal:  Pharm Res       Date:  2006-01-12       Impact factor: 4.200

Review 4.  The new B7s: playing a pivotal role in tumor immunity.

Authors:  Dallas B Flies; Lieping Chen
Journal:  J Immunother       Date:  2007-04       Impact factor: 4.456

5.  Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.

Authors:  Janet E Dancey; Kevin K Dobbin; Susan Groshen; J Milburn Jessup; Andrew H Hruszkewycz; Maria Koehler; Ralph Parchment; Mark J Ratain; Lalitha K Shankar; Walter M Stadler; Lawrence D True; Amy Gravell; Michael R Grever
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

6.  Genomic Analysis of Plasma Cell-Free DNA in Patients With Cancer.

Authors:  Geoffrey R Oxnard; Cloud P Paweletz; Lynette M Sholl
Journal:  JAMA Oncol       Date:  2017-06-01       Impact factor: 31.777

7.  Burdensome Research Procedures in Trials: Why Less Is More.

Authors:  Jonathan Kimmelman; David B Resnik; Jeffrey Peppercorn; Mark J Ratain
Journal:  J Natl Cancer Inst       Date:  2017-04-01       Impact factor: 13.506

8.  Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Authors:  Martin Reck; Delvys Rodríguez-Abreu; Andrew G Robinson; Rina Hui; Tibor Csőszi; Andrea Fülöp; Maya Gottfried; Nir Peled; Ali Tafreshi; Sinead Cuffe; Mary O'Brien; Suman Rao; Katsuyuki Hotta; Melanie A Leiby; Gregory M Lubiniecki; Yue Shentu; Reshma Rangwala; Julie R Brahmer
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Criteria for the use of omics-based predictors in clinical trials.

Authors:  Lisa M McShane; Margaret M Cavenagh; Tracy G Lively; David A Eberhard; William L Bigbee; P Mickey Williams; Jill P Mesirov; Mei-Yin C Polley; Kelly Y Kim; James V Tricoli; Jeremy M G Taylor; Deborah J Shuman; Richard M Simon; James H Doroshow; Barbara A Conley
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.